
Home Chapter Home Jobs Conferences Fellowships Books
Breast-malignant, males, children
Metaplastic carcinoma - Spindle cell subtype
Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.
Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)
Revised: 27 September 2009
Last major update: September 2009
Copyright: (c) 2002-2009, PathologyOutlines.com, Inc.
Definition
=========================================================================
● Sarcomatoid morphology, plus either limited (<5%) invasive carcinoma component or keratin positive sarcoma component (AJSP 2005;29:1456)
● Excludes low grade fibromatosis-like metaplastic tumors
● Note: some cases called spindle cell carcinoma in the literature have >5% invasive carcinoma component
Terminology
=========================================================================
● Also called sarcomatoid carcinoma or spindle cell carcinoma
Clinical
=========================================================================
● Sarcoma-like behavior (AJSP 2005;29:1456)
● Aggressive, high rate of local relapse and extranodal metastases
● Rate of nodal metastases varies from minimal (AJSP 2006;30:300) to 40% (Eur J Surg Oncol 2003;29:600)
Case reports
=========================================================================
● 80 year old woman (Univ Pittsburgh Case #294)
Micro images
=========================================================================
Spindle cell stroma
Various images
Positive stains
=========================================================================
● 34betaE12 (60%), SMA (56%) (Hum Pathol 2003;34:1009), p53
● Wide-spectrum keratin screening recommended since variable staining for CK5, CK14, Cam5.2 and AE1/AE3 (Histopathology 2002;40:556)
● Variable S100
Negative stains
=========================================================================
● Usually ER, PR, HER2 (J Clin Pathol 2006;59:1079), CD34, bcl2
End of Breast – Malignant, Males, Children > Metaplastic carcinoma > Spindle cell subtype
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions.